Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces Second Quarter 2013 Earnings Conference Call and Webcast Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(TM) Supernus Receives Tentative Approval for Trokendi XR(TM) Investor Presentation Supernus to Present at Two Investor Conferences Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019 Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019 Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes Pagination First page « first Previous page ‹ previous … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page next › Last page last »